Federally qualified health centers pay an important role in providing primary care and preventive services for patients who may have trouble accessing this care because of their insurance status, explained M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine.
Federally qualified health centers pay an important role in providing primary care and preventive services for patients who may have trouble accessing this care because of their insurance status, explained M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine.
Transcript
What role do federally qualified health centers play, and why are they important for uninsured and underinsured patients?
Federally qualified health centers, it’s a program that’s been around since the Johnson administration, so they’ve been around for a while now, and they always play an important role in safety net provision for primary care as well as for other services, mental health services, dental services, and various different special programs. Particularly for the uninsured, one of the grant stipulations, [Health Resources and Services Administration], is that they provide care regardless of a patient’s ability to pay and have a sliding-fee scale based on the person’s income and also take Medicaid, that’s an important qualification, too.
So, throughout these decades that the health center program has been around, they’ve served these places providing primary care and preventative services that may not be accessible for somebody without insurance. It’s a very important role and additionally, they are intentionally situated in medically underserved areas so that could be an urban area or rural area or somewhere with a special needs population so people that are already marginalized by the insurance health system because of their insurance status or because of other factors. They are experiencing homelessness, or they are a migrant farm worker, or other qualifying characteristics, they are going to receive more appropriate services in a way that are affordable and also accessible to them otherwise.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More